Jul 7, 2026 04:31PM
Jul 7, 2026 04:30PM
Jun 4, 2026 06:42AM
May 6, 2026 04:01PM
May 4, 2026 08:02AM
May 4, 2026 08:00AM
May 1, 2026 04:36PM Vanda launches motion sickness drug NEREUS after 40-year gap
May 1, 2026 04:35PM
Apr 28, 2026 07:12PM
Apr 9, 2026 11:03AM
Apr 9, 2026 11:02AM
Apr 9, 2026 06:42AM
Apr 8, 2026 04:45PM
Apr 8, 2026 04:44PM Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists
Mar 19, 2026 04:34PM
Mar 3, 2026 08:03AM
Mar 3, 2026 08:01AM
Feb 25, 2026 07:19AM
Feb 25, 2026 07:18AM
Feb 23, 2026 06:36AM
Feb 23, 2026 05:19AM Vanda Pharmaceuticals (VNDA) call put ratio 4.2 calls to 1 put into announces FDA approval of Bysanti tablets
Feb 20, 2026 05:59PM
Feb 20, 2026 05:59PM
Feb 11, 2026 04:01PM
Jan 8, 2026 07:01AM
Jan 8, 2026 07:00AM
Jan 5, 2026 06:41AM
Dec 31, 2025 04:25AM Vanda Pharmaceuticals (VNDA) PT Raised to $7.50 at Jefferies
Dec 30, 2025 06:13PM
Dec 30, 2025 06:13PM
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 15, 2025 07:00AM
Dec 4, 2025 04:22PM
Dec 4, 2025 04:21PM FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness
Dec 1, 2025 06:35AM
Nov 28, 2025 07:00AM
Nov 28, 2025 07:00AM
Nov 17, 2025 06:37PM
Oct 29, 2025 04:01PM
Oct 2, 2025 06:45AM
Oct 1, 2025 05:03PM Vanda Pharmaceuticals reaches dispute resolution framework with FDA
Oct 1, 2025 05:02PM
Sep 25, 2025 08:03AM
Sep 25, 2025 08:00AM
Aug 28, 2025 07:00AM
Aug 28, 2025 07:00AM
Aug 21, 2025 04:40PM
Aug 21, 2025 04:40PM Vanda Seeks FDA Commissioner Review of Outgoing CDER Director's Decision to Uphold Approval of Two Generic Versions of Hetlioz®
Aug 21, 2025 06:36AM

325,145 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All